Company Filing History:
2 out of 415 
2 out of 11 
Years Active: 2021-2023
Title: Jagdeep Singh Walia: Innovator in Gene Therapy
Introduction
Jagdeep Singh Walia is a prominent inventor based in Kingston, Canada. He has made significant contributions to the field of gene therapy, particularly in the treatment of GM2 gangliosidoses. With a total of 2 patents, Walia's work is paving the way for innovative therapeutic approaches.
Latest Patents
Walia's latest patents focus on methods and gene therapy constructs for treating GM2 gangliosidoses. These patents disclose novel gene therapy constructs that contain both HEXA and HEXB genes, aimed at treating conditions such as Sandhoff disease and Tay-Sach's disease. Additionally, the patents describe co-treatments using chaperone and anti-inflammatory agents to enhance the effects of gene therapy.
Career Highlights
Throughout his career, Walia has been associated with esteemed institutions such as Queen's University at Kingston and Kingston Health Sciences Centre. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Due to space constraints, the details of Walia's collaborations will not be included.
Conclusion
Jagdeep Singh Walia is a notable inventor whose work in gene therapy is making a significant impact in the treatment of genetic disorders. His innovative approaches and dedication to research continue to inspire advancements in the medical field.